Synovo

The science

The science behind the Synovo app

How a short smartphone video becomes an objective measure of how your joints are moving.

What we measure

What Synovo measures, and how it does it.

  1. Arthritis affects how far and how smoothly your joints move.
  2. Synovo guides you through a small set of simple movements and analyses the recording.
  3. It measures your range of motion across the joints that matter most for tracking arthritis.
  4. It combines that with a few short questions about how you have been feeling.

How the analysis works

  1. The analysis is Synovo's own in house movement technology.
  2. It runs on our secure servers, not on your phone.
  3. The details of how it works are proprietary.
  4. What matters for you is the output: a single, repeatable number.

The Digital Disease Activity Score

How Synovo's score relates to the one clinicians already use.

DAS28 in clinic

  • The score clinicians use for rheumatoid arthritis activity, measured only in clinic.
  • It combines tender and swollen joints, how you feel and sometimes a blood test.
  • It is well understood and widely used across the NHS.
  • Patients are seen in order of when they were last seen.
  • Someone getting worse can be missed, while someone who is well still attends.

Synovo's Digital Disease Activity Score

  • Designed to move in step with the DAS28.
  • Measured at home, as often as you like, the same way every time.
  • Trends over weeks and months are easy to see, so changes can be spotted sooner.
  • Patients can be seen when they need it.
  • It can mean fewer unnecessary visits.

Why an objective measure helps

Remembering how the last few weeks felt is hard. Pain is easy to underrate or overrate on any given day.

A measure taken the same way each time removes that guesswork. A real change then stands out from normal day to day variation.

For the NHS

  • Can help save clinic time, by seeing people when they need it rather than in turn.
  • Can help reduce costs, with fewer unnecessary appointments.
  • Can help free up clinic capacity for the patients who need it most.

For patients

  • Can help you be seen sooner when you need it.
  • Can help your care team act earlier to protect your joints.
  • Can mean fewer unnecessary trips to clinic.
  • Can support a better quality of life.

Our validation work

How we are checking Synovo against the clinic's own measure.

  • 94%

    Correlation between our Digital DAS and DAS28

    Against the clinic measure, in our work to date.

  • 97%

    Directional agreement on paired follow up changes

    Where DAS28 changed by 0.6 points or more

  1. We are validating Synovo against the DAS28 in clinical settings.
  2. In our work to date the score shows a strong correlation with the clinic measure.
  3. It shows good agreement on the direction of change between paired follow up assessments.
  4. It is live in a registered NHS Clinical Audit at Bedfordshire Hospitals NHS Foundation Trust.
  5. It also has an international deployment in Bahrain.

The figures on this site reflect Synovo's ongoing validation work and will be updated as that work continues. Synovo supports clinical care and does not replace assessment or advice from your own clinician.

Better for patients and the planet

A check-up at home instead of a hospital visit can save carbon.

  • 11.4 kg

    Traditional monitoring

    Estimated CO2e per patient per year, with an in person appointment for all RA patients.

  • 9.3 g

    Synovo

    Estimated CO2e per patient per year, with cloud processing for all RA patients.

  • 1.9 kg

    Each in person visit

    Estimated CO2e per visit, with an average of six visits per patient per year.

  • 114 thousand tonnes

    Projected saving

    CO2e saved annually in the UK, scaling to all arthritis patients.

These are estimates and projections, not measured results.

Why remote monitoring is greener

  • A check-up at home replaces an in person visit, each estimated at 1.9 kg CO2e.
  • Our cloud and assessment processing already runs lean, with only the computing we need.
  • Our target is for all server and assessment processing to run on 100 percent renewable energy by 2030.

The evidence

Why regular monitoring matters

Measuring arthritis often, and acting on the results, leads to better outcomes. Research also shows it can be done safely at home, with fewer trips to hospital.

  • 65% vs 16%

    Close monitoring leads to remission

    People whose arthritis was measured regularly and treated to a target reached remission far more often than those given routine care.

    Grigor et al., The Lancet, 2004. The TICORA study, a randomised controlled trial.Read the study (opens in a new tab)
  • Monthly

    Recommended by NICE

    NICE advises measuring disease activity, using a score such as DAS28, every month until remission or low disease activity is reached.

    NICE guideline NG100, 2018 (updated 2020). Rheumatoid arthritis in adults: management.Read the guideline (opens in a new tab)
  • 58% fewer

    Remote follow up works

    Following patients up remotely controlled their arthritis as well as clinic visits did, with far fewer face to face appointments.

    de Thurah et al., Arthritis Care and Research, 2018. A randomised controlled trial of 294 patients.Read the study (opens in a new tab)
  • 20 million+

    A growing need

    Over 20 million people, around a third of the UK, live with a musculoskeletal condition such as arthritis, putting real pressure on clinics.

    Versus Arthritis (now Arthritis UK), 2023. The State of Musculoskeletal Health.Read the report (opens in a new tab)